4-Bromo-6-fluoroisoquinolin-1(2H)-one, 95.0%, 500mg

Ethylammonium nitrate, min. 97%, 25 g, glass packaging

(R)-3-Hydroxypiperidin-2-one, 95+%, 250mg

6-Fluoro-3-methyl-1-benzothiophene-2-carboxylic acid, 97%, 10g

6-Fluoro-7-bromoisoquinoline, 97.0%, 10g

6,8-Difluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 97%, 1g

2-(2-Methyl-1H-imidazol-1-yl)pyridin-3-amine, 95%, 5g

Boc-Phe-OSu, 95.0%, 100g

1,4-Cyclohexanedione Monoethyleneketal>98.0%(GC)100g

4-Acetyl-2-bromopyridine, 95.0%, 1g

1-(4-Amino-3-ethoxyphenyl)piperidin-4-ol, 97%, 250mg

(E)-4,4,5,5-Tetramethyl-2-(pent-1-en-1-yl)-1,3,2-dioxaborolane, 98.0%, 250mg

Methyl (2e)-3-(2,4-dichlorophenyl)-2-propenoate, 98%, 100g